| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:3143.)
© 2002 American Heart Association, Inc.
ATP III Final Report PDF |
Related Article:
This article has been cited by other articles:
![]() |
D. D. Waters, C. Brotons, C.-W. Chiang, J. Ferrieres, J. Foody, J. W. Jukema, R. D. Santos, J. Verdejo, M. Messig, R. McPherson, et al. Lipid Treatment Assessment Project 2: A Multinational Survey to Evaluate the Proportion of Patients Achieving Low-Density Lipoprotein Cholesterol Goals Circulation, July 7, 2009; 120(1): 28 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. THENGAMPALLIL and S. S THENGAMPALLIL Pharmacology in Radiology Radiol. Technol., July 1, 2009; 80(6): 547 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chen, W. Wang, Y. Huang, P. Shen, D. Pei, H. Yu, H. Shi, Q. Zhang, J. Xu, Y. Lv, et al. Community-based study on CKD subjects and the associated risk factors Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2117 - 2123. [Abstract] [Full Text] [PDF] |
||||
![]() |
X Li, K L Monda, H H H Goring, K Haack, S A Cole, V P Diego, L Almasy, S Laston, B V Howard, N M Shara, et al. Genome-wide linkage scan for plasma high density lipoprotein cholesterol, apolipoprotein A-1 and triglyceride variation among American Indian populations: the Strong Heart Family Study J. Med. Genet., July 1, 2009; 46(7): 472 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
J J Brugts, T Yetgin, S E Hoeks, A M Gotto, J Shepherd, R G J Westendorp, A J M de Craen, R H Knopp, H Nakamura, P Ridker, et al. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials BMJ, June 30, 2009; 338(jun30_1): b2376 - b2376. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Sturm, A. Tschoner, J. Engl, S. Kaser, M. Laimer, C. Ciardi, A. Klaus, H. Weiss, A. Sandhofer, J. R. Patsch, et al. Effect of bariatric surgery on both functional and structural measures of premature atherosclerosis Eur. Heart J., June 4, 2009; (2009) ehp211v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Garcia and V. Fuster An Ounce of Prevention With a Calcium Score Scan? J. Am. Coll. Cardiol. Img., June 1, 2009; 2(6): 689 - 691. [Full Text] [PDF] |
||||
![]() |
M. R. Bonsignore and J. Eckel Metabolic aspects of obstructive sleep apnoea syndrome Eur. Respir. Rev., June 1, 2009; 18(112): 113 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Gannage-Yared, R. Chedid, S. Khalife, E. Azzi, F. Zoghbi, and G. Halaby Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population Eur. J. Endocrinol., June 1, 2009; 160(6): 965 - 971. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lumey, A. D Stein, H. S Kahn, and J. Romijn Lipid profiles in middle-aged men and women after famine exposure during gestation: the Dutch Hunger Winter Families Study Am. J. Clinical Nutrition, June 1, 2009; 89(6): 1737 - 1743. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Brautbar, C. M. Ballantyne, K. Lawson, V. Nambi, L. Chambless, A. R. Folsom, J. T. Willerson, and E. Boerwinkle Impact of Adding a Single Allele in the 9p21 Locus to Traditional Risk Factors on Reclassification of Coronary Heart Disease Risk and Implications for Lipid-Modifying Therapy in the Atherosclerosis Risk in Communities Study Circ Cardiovasc Genet, June 1, 2009; 2(3): 279 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Selvin, A. Kottgen, and J. Coresh Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999-2002 Eur. Heart J., May 31, 2009; (2009) ehp195v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kodama, K. Saito, S. Tanaka, M. Maki, Y. Yachi, M. Asumi, A. Sugawara, K. Totsuka, H. Shimano, Y. Ohashi, et al. Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women: A Meta-analysis JAMA, May 20, 2009; 301(19): 2024 - 2035. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rizzo, K. Berneis, M. Hersberger, I. Pepe, G. Di Fede, G. B. Rini, G. A. Spinas, and E. Carmina Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype Hum. Reprod., May 19, 2009; (2009) dep121v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Mahmoodi, R. T. Gansevoort, N. J. G. M. Veeger, A. G. Matthews, G. Navis, H. L. Hillege, J. van der Meer, and for the Prevention of Renal and Vascular End-stage Microalbuminuria and Risk of Venous Thromboembolism JAMA, May 6, 2009; 301(17): 1790 - 1797. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Huang A comprehensive definition for metabolic syndrome Dis. Model. Mech., May 1, 2009; 2(5-6): 231 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M Gul, N. Ahmadi, Z. Wang, C. Jamieson, K. Nasir, R. Metcalfe, H. S Hecht, C. J Hartley, and M. Naghavi Digital thermal monitoring of vascular function: a novel tool to improve cardiovascular risk assessment Vascular Medicine, May 1, 2009; 14(2): 143 - 148. [Abstract] [PDF] |
||||
![]() |
P. Cirillo, Y. Y. Sautin, J. Kanellis, D.-H. Kang, L. Gesualdo, T. Nakagawa, and R. J. Johnson Systemic inflammation, metabolic syndrome and progressive renal disease Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1384 - 1387. [Full Text] [PDF] |
||||
![]() |
F. Wiesbauer, H. Blessberger, D. Azar, G. Goliasch, O. Wagner, L. Gerhold, K. Huber, K. Widhalm, F. Abdolvahab, G. Sodeck, et al. Familial-combined hyperlipidaemia in very young myocardial infarction survivors (<=40 years of age) Eur. Heart J., May 1, 2009; 30(9): 1073 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M Ordovas Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1509S - 1517S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Lewis, K. M. Fox, M. F. Bullano, S. Grandy, and for the SHIELD Study Group Knowledge of Heart Disease Risk Among SHIELD Respondents With Dyslipidemia Circ Cardiovasc Qual Outcomes, May 1, 2009; 2(3): 207 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Junyent, D. K. Arnett, M. Y. Tsai, E. K. Kabagambe, R. J. Straka, M. Province, P. An, C.-Q. Lai, L. D. Parnell, J. Shen, et al. Genetic Variants at the PDZ-Interacting Domain of the Scavenger Receptor Class B Type I Interact with Diet to Influence the Risk of Metabolic Syndrome in Obese Men and Women J. Nutr., May 1, 2009; 139(5): 842 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Doherty New insights into the epidemiology of gout Rheumatology, May 1, 2009; 48(suppl_2): ii2 - ii8. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Noda, H. Iso, F. Irie, T. Sairenchi, E. Ohtaka, M. Doi, Y. Izumi, and H. Ohta Low-Density Lipoprotein Cholesterol Concentrations and Death Due to Intraparenchymal Hemorrhage: The Ibaraki Prefectural Health Study Circulation, April 28, 2009; 119(16): 2136 - 2145. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Maruthur, N.-Y. Wang, and L. J. Appel Lifestyle Interventions Reduce Coronary Heart Disease Risk: Results From the PREMIER Trial Circulation, April 21, 2009; 119(15): 2026 - 2031. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Postorino, C. Marino, G. Tripepi, C. Zoccali, and on behalf of the CREDIT (Calabria Registry of Dial Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. J. Am. Coll. Cardiol., April 14, 2009; 53(15): 1265 - 1272. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Xu, L. Zhang, P. Zhang, F. Wang, L. Zuo, and H. Wang Comparison of the prevalence of chronic kidney disease among different ethnicities: Beijing CKD survey and American NHANES Nephrol. Dial. Transplant., April 1, 2009; 24(4): 1220 - 1226. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Nuzum and T. Merz Macrovascular Complications of Diabetes Mellitus Journal of Pharmacy Practice, April 1, 2009; 22(2): 135 - 148. [Abstract] [PDF] |
||||
![]() |
G. Saposnik, S. G. Goodman, L. A. Leiter, R. T. Yan, D. H. Fitchett, N. H. Bayer, A. Casanova, A. Langer, A. T. Yan, for the Vascular Protection (VP), et al. Applying the Evidence: Do Patients With Stroke, Coronary Artery Disease, or Both Achieve Similar Treatment Goals? Stroke, April 1, 2009; 40(4): 1417 - 1424. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Ford, C. Li, G. Zhao, W. S. Pearson, and A. H. Mokdad Hypertriglyceridemia and Its Pharmacologic Treatment Among US Adults Arch Intern Med, March 23, 2009; 169(6): 572 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Thompson and G. T. Gau Hypertriglyceridemia and Its Pharmacologic Treatment Among US Adults--Invited Commentary Arch Intern Med, March 23, 2009; 169(6): 578 - 579. [Full Text] [PDF] |
||||
![]() |
C. G. Magnussen, A. Venn, R. Thomson, M. Juonala, S. R. Srinivasan, J. S.A. Viikari, G. S. Berenson, T. Dwyer, and O. T. Raitakari The association of pediatric low- and high-density lipoprotein cholesterol dyslipidemia classifications and change in dyslipidemia status with carotid intima-media thickness in adulthood evidence from the cardiovascular risk in Young Finns study, the Bogalusa Heart study, and the CDAH (Childhood Determinants of Adult Health) study. J. Am. Coll. Cardiol., March 10, 2009; 53(10): 860 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
CORONARY REVASCULARIZATION WRITING GROUP, M. R. Patel, G. J. Dehmer, J. W. Hirshfeld, P. K. Smith, and J. A. Spertus ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology: Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography Circulation, March 10, 2009; 119(9): 1330 - 1352. [Full Text] [PDF] |
||||
![]() |
I. Goldenberg, V. Boyko, A. Tennenbaum, D. Tanne, S. Behar, and V. Guetta Long-term Benefit of High-Density Lipoprotein Cholesterol-Raising Therapy With Bezafibrate: 16-Year Mortality Follow-up of the Bezafibrate Infarction Prevention Trial Arch Intern Med, March 9, 2009; 169(5): 508 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Silverberg, W. Leyden, L. Hurley, A. S. Go, C. P. Quesenberry Jr., D. Klein, and M. A. Horberg Response to Newly Prescribed Lipid-Lowering Therapy in Patients With and Without HIV Infection Ann Intern Med, March 3, 2009; 150(5): 301 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Gidding, A. H. Lichtenstein, M. S. Faith, A. Karpyn, J. A. Mennella, B. Popkin, J. Rowe, L. Van Horn, and L. Whitsel Implementing American Heart Association Pediatric and Adult Nutrition Guidelines: A Scientific Statement From the American Heart Association Nutrition Committee of the Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular Disease in the Young, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, and Council for High Blood Pressure Research Circulation, March 3, 2009; 119(8): 1161 - 1175. [Full Text] [PDF] |
||||
![]() |
M. Srinivasan, B. A. Irving, K. Dhatariya, K. A. Klaus, S. J. Hartman, J. P. McConnell, and K. S. Nair Effect of Dehydroepiandrosterone Replacement on Lipoprotein Profile in Hypoadrenal Women J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 761 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hopkins and M. Limacher The Role of Aspirin in Cardiovascular Disease Prevention in Women American Journal of Lifestyle Medicine, March 1, 2009; 3(2): 123 - 134. [Abstract] [PDF] |
||||
![]() |
D. W. Haupt, L. C. Rosenblatt, E. Kim, R. A. Baker, R. Whitehead, and J. W. Newcomer Prevalence and Predictors of Lipid and Glucose Monitoring in Commercially Insured Patients Treated With Second-Generation Antipsychotic Agents Am J Psychiatry, March 1, 2009; 166(3): 345 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cirillo, M. S. Gersch, W. Mu, P. M. Scherer, K. M. Kim, L. Gesualdo, G. N. Henderson, R. J. Johnson, and Y. Y. Sautin Ketohexokinase-Dependent Metabolism of Fructose Induces Proinflammatory Mediators in Proximal Tubular Cells J. Am. Soc. Nephrol., March 1, 2009; 20(3): 545 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M Trompeter and D. E Havrda Impact of Obtaining Medications from Pharmaceutical Company Assistance Programs on Therapeutic Goals Ann. Pharmacother., March 1, 2009; 43(3): 469 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mora, J. D. Otvos, N. Rifai, R. S. Rosenson, J. E. Buring, and P. M Ridker Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women Circulation, February 24, 2009; 119(7): 931 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Patel, G. J. Dehmer, J. W. Hirshfeld, P. K. Smith, and J. A. Spertus ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography J. Am. Coll. Cardiol., February 10, 2009; 53(6): 530 - 553. [Full Text] [PDF] |
||||
![]() |
J. A. Driver, G. Logroscino, J. M. Gaziano, and T. Kurth Incidence and remaining lifetime risk of Parkinson disease in advanced age Neurology, February 3, 2009; 72(5): 432 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Cooper-DeHoff, M. A. Pacanowski, and C. J. Pepine Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum. J. Am. Coll. Cardiol., February 3, 2009; 53(5 Suppl): S28 - S34. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Seth Loomba and R. Arora Fibrates: where are we now? Therapeutic Advances in Cardiovascular Disease, February 1, 2009; 3(1): 91 - 96. [Abstract] [PDF] |
||||
![]() |
S. P. Dunn, B. Bleske, M. Dorsch, T. Macaulay, B. Van Tassell, and O. Vardeny Nutrition and Heart Failure: Impact of Drug Therapies and Management Strategies Nutr Clin Pract, February 1, 2009; 24(1): 60 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Palomba, A. Falbo, F. Zullo, and F. Orio Jr. Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review Endocr. Rev., February 1, 2009; 30(1): 1 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kim, S. K. Park, W. Han, D.-H. Kim, Y.-C. Hong, E. H. Ha, S.-H. Ahn, D.-Y. Noh, D. Kang, and K.-Y. Yoo Serum High-Density Lipoprotein Cholesterol and Breast Cancer Risk by Menopausal Status, Body Mass Index, and Hormonal Receptor in Korea Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 508 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. NIKPOUR, D. D. GLADMAN, D. IBANEZ, I. N. BRUCE, R. J. BURNS, and M. B. UROWITZ Myocardial Perfusion Imaging in Assessing Risk of Coronary Events in Patients with Systemic Lupus Erythematosus J Rheumatol, February 1, 2009; 36(2): 288 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mora, K. Musunuru, and R. S. Blumenthal The Clinical Utility of High-Sensitivity C-Reactive Protein in Cardiovascular Disease and the Potential Implication of JUPITER on Current Practice Guidelines Clin. Chem., February 1, 2009; 55(2): 219 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Qiao, T. Laatikainen, B. Zethelius, B. Stegmayr, M. Eliasson, P. Jousilahti, and J. Tuomilehto Comparison of Definitions of Metabolic Syndrome in Relation to the Risk of Developing Stroke and Coronary Heart Disease in Finnish and Swedish Cohorts Stroke, February 1, 2009; 40(2): 337 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Azadbakht and A. Esmaillzadeh Red Meat Intake Is Associated with Metabolic Syndrome and the Plasma C-Reactive Protein Concentration in Women J. Nutr., February 1, 2009; 139(2): 335 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Maki, M. S. Reeves, M. Farmer, K. Yasunaga, N. Matsuo, Y. Katsuragi, M. Komikado, I. Tokimitsu, D. Wilder, F. Jones, et al. Green Tea Catechin Consumption Enhances Exercise-Induced Abdominal Fat Loss in Overweight and Obese Adults J. Nutr., February 1, 2009; 139(2): 264 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Demonty, R. T. Ras, H. C. M. van der Knaap, G. S. M. J. E. Duchateau, L. Meijer, P. L. Zock, J. M. Geleijnse, and E. A. Trautwein Continuous Dose-Response Relationship of the LDL-Cholesterol-Lowering Effect of Phytosterol Intake J. Nutr., February 1, 2009; 139(2): 271 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Robinson, S. Wang, B. J. Smith, and T. A. Jacobson Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. J. Am. Coll. Cardiol., January 27, 2009; 53(4): 316 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Budoff, K. Nasir, R. L. McClelland, R. Detrano, N. Wong, R. S. Blumenthal, G. Kondos, and R. A. Kronmal Coronary Calcium Predicts Events Better With Absolute Calcium Scores Than Age-Sex-Race/Ethnicity Percentiles MESA (Multi-Ethnic Study of Atherosclerosis). J. Am. Coll. Cardiol., January 27, 2009; 53(4): 345 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Schiele and N. Meneveau Are you as old as your arteries or as old as your coronary artery calcification score? J. Am. Coll. Cardiol., January 27, 2009; 53(4): 353 - 354. [Full Text] [PDF] |
||||
![]() |
V. Nambi and C. M. Ballantyne "Risky Business": Ten Years Is Not a Lifetime Circulation, January 27, 2009; 119(3): 362 - 364. [Full Text] [PDF] |
||||
![]() |
N. K. Choudhry Copayment Levels and Medication Adherence: Less Is More Circulation, January 27, 2009; 119(3): 365 - 367. [Full Text] [PDF] |
||||
![]() |
WRITING GROUP MEMBERS, D. Lloyd-Jones, R. Adams, M. Carnethon, G. De Simone, T. B. Ferguson, K. Flegal, E. Ford, K. Furie, A. Go, et al. Heart Disease and Stroke Statistics--2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 27, 2009; 119(3): e21 - e181. [Full Text] [PDF] |
||||
![]() |
R. E. Schmieder, T. Philipp, J. Guerediaga, M. Gorostidi, B. Smith, N. Weissbach, M. Maboudian, J. Botha, and H. van Ingen Long-Term Antihypertensive Efficacy and Safety of the Oral Direct Renin Inhibitor Aliskiren: A 12-Month Randomized, Double-Blind Comparator Trial With Hydrochlorothiazide Circulation, January 27, 2009; 119(3): 417 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Berry, K. Liu, A. R. Folsom, C. E. Lewis, J. J. Carr, J. F. Polak, S. Shea, S. Sidney, D. H. O'Leary, C. Chan, et al. Prevalence and Progression of Subclinical Atherosclerosis in Younger Adults With Low Short-Term but High Lifetime Estimated Risk For Cardiovascular Disease: The Coronary Artery Risk Development in Young Adults Study and Multi-Ethnic Study of Atherosclerosis Circulation, January 27, 2009; 119(3): 382 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Paynter, D. I. Chasman, J. E. Buring, D. Shiffman, N. R. Cook, and P. M. Ridker Cardiovascular Disease Risk Prediction With and Without Knowledge of Genetic Variation at Chromosome 9p21.3 Ann Intern Med, January 20, 2009; 150(2): 65 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Grammer, W. Marz, W. Renner, B. O. Bohm, and M. M. Hoffmann C-reactive protein genotypes associated with circulating C-reactive protein but not with angiographic coronary artery disease: the LURIC study Eur. Heart J., January 2, 2009; 30(2): 170 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. AYDOGAN, S. ISBIR, O. KURNAZ, U. GORMUS, and T. ISBIR Associations of Lipoprotein Lipase S447X and Apolipoprotein E Genotypes with Low-density Lipoprotein Subfractions in Turkish Patients with Coronary Artery Disease In Vivo, January 1, 2009; 23(1): 155 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Savopoulos, A. I. Hatzitolios, N. A. Katsiki, M. Baltatzi, M. Kosmidou, N. Raikos, D. P. Mikhailidis, A. G. Ziakas, G. Kaiafa, and N. Tsesmeli Sodium-Lithium Countertransport Activity in Healthy, Dyslipidemic, and Hypertensive Individuals Angiology, January 1, 2009; 59(6): 727 - 735. [Abstract] [PDF] |
||||
![]() |
E. S. Spatz, M. E. Canavan, and M. M. Desai From Here to JUPITER: Identifying New Patients for Statin Therapy Using Data From the 1999-2004 National Health and Nutrition Examination Survey Circ Cardiovasc Qual Outcomes, January 1, 2009; 2(1): 41 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. West, R. F. Hamman, E. J. Mayer-Davis, R. B. D'Agostino Jr., S. M. Marcovina, A. D. Liese, P. S. Zeitler, S. R. Daniels, and D. Dabelea Cardiovascular Risk Factors Among Youth With and Without Type 2 Diabetes: Differences and possible mechanisms Diabetes Care, January 1, 2009; 32(1): 175 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Ross, S N Blair, M Godwin, S Hotz, P T Katzmarzyk, M Lam, L Levesque, and S MacDonald Prevention and Reduction of Obesity through Active Living (PROACTIVE): rationale, design and methods Br. J. Sports Med., January 1, 2009; 43(1): 57 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Saylor and M. R. Smith Prostate Cancer Survivorship: Metabolic Complications of Androgen Deprivation Therapy ASCO Educational Book, January 1, 2009; 2009(1): 263 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Rodriguez-Colon, J. Mo, Y. Duan, J. Liu, J. E. Caulfield, X. Jin, and D. Liao Metabolic Syndrome Clusters and the Risk of Incident Stroke: The Atherosclerosis Risk in Communities (ARIC) Study Stroke, January 1, 2009; 40(1): 200 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Zhu, W. M. Awni, B. Hosmane, M. T. Kelly, D. J. Sleep, J. C. Stolzenbach, K. Wan, T. O. Chira, and R. S. Pradhan ABT-335, the Choline Salt of Fenofibric Acid, Does Not Have a Clinically Significant Pharmacokinetic Interaction With Rosuvastatin in Humans J. Clin. Pharmacol., January 1, 2009; 49(1): 63 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Uto-Kondo, R. Ohmori, C. Kiyose, Y. Kishimoto, H. Saito, O. Igarashi, and K. Kondo Tocotrienol Suppresses Adipocyte Differentiation and Akt Phosphorylation in 3T3-L1 Preadipocytes J. Nutr., January 1, 2009; 139(1): 51 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Deji, S. Kume, S.-i. Araki, M. Soumura, T. Sugimoto, K. Isshiki, M. Chin-Kanasaki, M. Sakaguchi, D. Koya, M. Haneda, et al. Structural and functional changes in the kidneys of high-fat diet-induced obese mice Am J Physiol Renal Physiol, January 1, 2009; 296(1): F118 - F126. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vergeer, M. L. Bots, S. I. van Leuven, D. C. Basart, E. J. Sijbrands, G. W. Evans, D. E. Grobbee, F. L. Visseren, A. F. Stalenhoef, E. S. Stroes, et al. Cholesteryl Ester Transfer Protein Inhibitor Torcetrapib and Off-Target Toxicity: A Pooled Analysis of the Rating Atherosclerotic Disease Change by Imaging With a New CETP Inhibitor (RADIANCE) Trials Circulation, December 9, 2008; 118(24): 2515 - 2522. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lamarche Review of the Effect of Dairy Products on Non-Lipid Risk Factors for Cardiovascular Disease J. Am. Coll. Nutr., December 1, 2008; 27(6): 741S - 746S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Schulz, M. C. Zanarini, A. Bateman, M. Bohus, H. C. Detke, Q. Trzaskoma, Y. Tanaka, D. Lin, W. Deberdt, and S. Corya Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study The British Journal of Psychiatry, December 1, 2008; 193(6): 485 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Ouellet, S. J. Weisnagel, J. Marois, J. Bergeron, P. Julien, R. Gougeon, A. Tchernof, B. J. Holub, and H. Jacques Dietary Cod Protein Reduces Plasma C-Reactive Protein in Insulin-Resistant Men and Women J. Nutr., December 1, 2008; 138(12): 2386 - 2391. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Dunbar, P. Reddy, N. Davis-Lameloise, B. Philpot, T. Laatikainen, A. Kilkkinen, S. J. Bunker, J. D. Best, E. Vartiainen, S. Kai Lo, et al. Depression: An Important Comorbidity With Metabolic Syndrome in a General Population Diabetes Care, December 1, 2008; 31(12): 2368 - 2373. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Jacobson, D. A. Wertz, T. Hoy, A. Kuznik, D. Grochulski, and M. Cziraky Comparison of Cardiovascular Event Rates in Patients Without Cardiovascular Disease in Whom Atorvastatin or Simvastatin Was Newly Initiated Mayo Clin. Proc., December 1, 2008; 83(12): 1316 - 1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Aijaz, K. A. Ammar, F. Lopez-Jimenez, M. M. Redfield, S. J. Jacobsen, and R. J. Rodeheffer Abnormal Cardiac Structure and Function in the Metabolic Syndrome: A Population-Based Study Mayo Clin. Proc., December 1, 2008; 83(12): 1350 - 1357. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Pomeroy and A. Worsley Nutrition care for adult cardiac patients: Australian general practitioners' perceptions of their roles Fam. Pract., December 1, 2008; 25(suppl_1): i123 - i129. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. McGeechan, P. Macaskill, L. Irwig, G. Liew, and T. Y. Wong Assessing New Biomarkers and Predictive Models for Use in Clinical Practice: A Clinician's Guide Arch Intern Med, November 24, 2008; 168(21): 2304 - 2310. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Gibbons, D. W. Jones, T. J. Gardner, L. B. Goldstein, J. H. Moller, and C. W. Yancy The American Heart Association's 2008 Statement of Principles for Healthcare Reform Circulation, November 18, 2008; 118(21): 2209 - 2218. [Full Text] [PDF] |
||||
![]() |
J.-C. Fruchart, F. M Sacks, M. P Hermans, G. Assmann, W V. Brown, R. Ceska, M J. Chapman, P. M Dodson, P. Fioretto, H. N Ginsberg, et al. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients Diabetes and Vascular Disease Research, November 1, 2008; 5(4): 319 - 335. [Abstract] [PDF] |
||||
![]() |
V. Vuksan, A. L Jenkins, D. J. Jenkins, A. L Rogovik, J. L Sievenpiper, and E. Jovanovski Using cereal to increase dietary fiber intake to the recommended level and the effect of fiber on bowel function in healthy persons consuming North American diets Am. J. Clinical Nutrition, November 1, 2008; 88(5): 1256 - 1262. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |